Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Intervertebral Body Fusion Spacers Help Treat Complex Spinal Pathologies

By HospiMedica International staff writers
Posted on 31 Jul 2009
An innovative system of intervertebral body spacer cages made of polyetheretherketone (PEEK) provides a superior anatomical reconstruction for interbody spinal fusion. More...


The Aleutian family of intervertebral body spacers includes five different systems that offer a full array of anatomically designed PEEK interbody options, including anterior-lumbar interbody fusion (ALIF), small-anterior (Cervical), posterior-lumbar interbody fusion (PLIF), anatomically narrow (AN), and transforaminal-lumbar interbody fusion (TLIF). Among the features of the spacers in the system (supplied in a large range of implant heights to accommodate differing anatomy sizes) are an elastic modulus close to that of cortical bone, allowing for load sharing while minimizing stress shielding; radiopaque tantalum markers at either end of the implant provide visualization for confirming placement, while body radiolucency allows for more accurate fusion assessment; a bulleted nose design allowing for ease-of-insertion; and a convex design that minimizes endplate preparation. A hollow, fenestrated geometry permits bony ingrowth, and self-retaining teeth assist in gripping the endplates and resisting expulsion. The system also has a complete offering of disc and endplate preparation instruments, including spreaders, scrapers, a bone packing device, and trial spacers to ensure accurate placement. The Aleutian family of intervertebral body spacers is the product of K2M Inc. (Leesburg, VA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"FDA clearance for the Aleutian Spacer Systems to be marketed as intervertebral body fusion devices provides surgeons with multiple surgical applications in the cervical and lumbar spine for the treatment of Degenerative Disc Disease (DDD) and spondylolisthesis, as well as more complex applications,” said Eric Major, president and CEO of K2M. "The anatomically designed implants and differentiated surgical instruments facilitate and streamline surgical applications. The Aleutian family of products complements our comprehensive product portfolio of best-in-class systems for treating all types of complex spinal pathologies.”

PEEK is a biocompatible and stable polymer used in the development of implantable medical devices and pharmaceutical applications having blood or tissue contact for more than 30 days. It is available in a range of forms that offer virtually unlimited design solutions, and can be processed via injection molding, extrusion, or compression molding. PEEK is usually available in three grades: standard, medium, and low viscosity.

Related Links:

K2M



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.